Personalized Prehabilitation: A Pathway to Improved Frailty Metrics and Survival in Liver Transplant Candidates.
Key claim: Personalized physical therapy prehabilitation improves frailty metrics in liver transplant candidates, with an improvement of at least 0.4 on the Liver Frailty Index conferring an approximate 50% reduction in mortality.
Abstract
BACKGROUND & AIMS: Outpatient prehabilitation can potentially improve frailty in liver transplant (LT) candidates. Our aim was to determine the impact of prehabilitation on physical fitness and mortality and to identify the minimum clinically important change needed to improve survival. METHODS: In this ambispective cohort study, LT candidates underwent baseline evaluation with a dedicated physical therapist and were prescribed a personalized prehabilitation program based on their functional status. The Liver Frailty Index (LFI), 6-minute walk test (6MWT), and gait speed test (GST) were assessed. Multilevel linear mixed-effects models and multivariable survival analyses were fitted, including competing risks models against LT. RESULTS: A total of 1275 patients (59% male; mean age, 57 ± 11 years; Model for End-stage Liver Disease, 14 ± 6) attended 1973 LT-physical therapist visits. Of these, 355 attended 2 or more follow-up visits, participating in the prehabilitation program. At baseline, the median LFI was 3.8 (interquartile range [IQR], 3.2-4.4), the median 6MWT was 336 meters (IQR, 243-403 meters), and the median GST was 1 (IQR, 0.8-1.2); 23%, 26%, and 29% of the cohort were frail by each tool, respectively. Among subjects who improved the LFI (n = 226/352), the absolute change was -0.39 (IQR, -0.32 to -0.46), and for the 6MWT (n = 212/334), it was 54 meters (IQR, 43-64 meters); fewer than one-half improved the GST. A total of 667 patients (55%) were waitlisted, 462 patients (37%) were transplanted, and 335 patients (26%) died. LFI improvement by at least 0.4 was associated with a ∼50% reduction in mortality (hazard ratio, 0.56; P = .037). Improvement in the 6MWT was not associated with a survival advantage. CONCLUSIONS: Individualized prehabilitation in LT candidates was associated with significant improvement in the LFI and 6MWT. A minimum LFI improvement of 0.4 was associated with improved survival and could be considered a minimal clinically important difference for frailty interventions in LT candidates.
Why this matters
[human-observational] This study connects longitudinal improvement in a clinical frailty measure with mortality in liver transplant candidates, extending assessment beyond baseline risk stratification to tracking change during prehabilitation. [human-observational] The ≥0.4-point Liver Frailty Index decrease is an outcome-associated threshold in this setting, not a validated surrogate for treatment-induced survival benefit or evidence of reversal of biological aging.